Emphasizes the need to integrate palliative care for patients with valvular heart disease who are ineligible for transcatheter interventions.
The increased availability of transcatheter options for the management of valvular heart disease will increase the assessment of people with life-limiting conditions for whom treatment may not be an option. It is pivotal to bridge cardiac innovation and palliation to optimize patient outcomes.
No takes yet. Share an insight, caveat, or question.
Lauck et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: